Commentary: Come on maybe lyse my fire? Cell-free DNA: A potential novel therapeutic target for postcardiopulmonary bypass inflammation

J Thorac Cardiovasc Surg. 2022 Aug;164(2):376-377. doi: 10.1016/j.jtcvs.2021.11.015. Epub 2021 Nov 12.

Authors

Paul Joseph Devlin¹, Sunjay Kaushal²

Affiliations

¹ Division of Cardiac Surgery, Bluhm Cardiovascular Institute, Northwestern University Feinberg School of Medicine, Chicago, Ill. Electronic address: Paul-Devlin@northwestern.edu.
² Division of Cardiac Surgery, Department of Surgery, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Ill.

PMID: 34865840
DOI: 10.1016/j.jtcvs.2021.11.015

No abstract available

Publication types

Editorial
Comment

MeSH terms

Cardiopulmonary Bypass
Cell-Free Nucleic Acids*
Humans
Inflammation

Substances

Cell-Free Nucleic Acids